查找临床试验
已按「强直性脊柱炎」检索，对应国际通用词 ankylosing spondylitis
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:07，每 5 分钟自动同步The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
China
年龄 18 Years – 不限
China-Japan Friendship Hospital
Clinical Trial Study on the Improved New Method of Acupotomy for AS
China
年龄 18 Years – 75 Years
China-Japan Friendship Hospital
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
China
年龄 18 Years – 75 Years
China-Japan Friendship Hospital
Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study
China
年龄 18 Years – 75 Years
China-Japan Friendship Hospital
Bidirectional Cohort Study of Nanfang Spondyloarthritis
China
年龄 10 Years – 59 Years
Nanfang Hospital, Southern Medical University
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
China
年龄 18 Years – 70 Years
Jiangsu vcare pharmaceutical technology co., LTD
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
China
年龄 18 Years – 59 Years
Nanfang Hospital, Southern Medical University
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
China
年龄 18 Years – 65 Years
Tasly Pharmaceutical Group Co., Ltd
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
China
年龄 18 Years – 不限
Lynk Pharmaceuticals Co., Ltd
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
United States、Brazil、Canada、Chile、China 等 12 国
年龄 18 Years – 80 Years
Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)
China
年龄 18 Years – 不限
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
China
年龄 18 Years – 80 Years
Tongji Hospital